Ann: Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial, page-16

JimJam2020 it's very simple, as your username puts it as of 2020 ASX markets now demand one thing, revenue. You can have all the fancy announcements but until then, we aint moving. The only chance this moves is one of a handful of things IMO, which you shouldn't listen to cos I am dumb dumb.

• Serious Revenue from Clinics
• Large Phase 2 study with staggering results - I would say this would move SP maybe 100%

I cannot comment on NASDAQ as well I am a fish out of water when it comes to that market and phase results will take place in that market if we move.

/back to IDS/IPS DEV Huddles.